Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Denning

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Infection and Immunity|December 1, 1992
Lack of vessel wall elastolysis in human invasive pulmonary aspergillosisD W Denning, P N Ward, L E Fenelon, et al.
Medical Mycology|October 20, 1998
Polar lipids of Aspergillus fumigatus, A. niger, A. nidulans, A. flavus and A. terreusM Birch, D B Drucker, I Riba, et al.
Postgraduate Medical Journal|January 1, 1987
Idiopathic oedema and diureticsM G Dunnigan, D W Denning, J A Henry, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida sppH M Wardle, D Law, C B Moore, et al.
Chest|September 1, 1991
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazoleD W Denning, J E Van Wye, N J Lewiston, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 27, 2013
A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosisN L D Smith, J Hankinson, A Simpson, et al.
Lancet (London, England)|December 13, 1986
Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activatorD W Denning, L Gilliland, A Hewlett, et al.
Medical Mycology|November 10, 2018
Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodologyC Lass-Flörl, M Cuenca-Estrella, D W Denning, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosisP E Verweij, K L Oakley, J Morrissey, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus sppJ Mosquera, A Sharp, C B Moore, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Infection and Immunity|December 1, 1992
Lack of vessel wall elastolysis in human invasive pulmonary aspergillosisD W Denning, P N Ward, L E Fenelon, et al.
Medical Mycology|October 20, 1998
Polar lipids of Aspergillus fumigatus, A. niger, A. nidulans, A. flavus and A. terreusM Birch, D B Drucker, I Riba, et al.
Postgraduate Medical Journal|January 1, 1987
Idiopathic oedema and diureticsM G Dunnigan, D W Denning, J A Henry, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida sppH M Wardle, D Law, C B Moore, et al.
Chest|September 1, 1991
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazoleD W Denning, J E Van Wye, N J Lewiston, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 27, 2013
A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosisN L D Smith, J Hankinson, A Simpson, et al.
Lancet (London, England)|December 13, 1986
Peripheral symmetrical gangrene successfully treated with epoprostenol and tissue plasminogen activatorD W Denning, L Gilliland, A Hewlett, et al.
Medical Mycology|November 10, 2018
Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodologyC Lass-Flörl, M Cuenca-Estrella, D W Denning, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosisP E Verweij, K L Oakley, J Morrissey, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2002
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus sppJ Mosquera, A Sharp, C B Moore, et al.
Pageof 28